Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074373 · ClinicalTrials.gov registry record
The Research Registry for Neonatal Lupus
A clinical trial of Systemic Lupus Erythematosus and Sjogren's Syndrome, sponsored by NYU Langone Health.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00074373: Completed study of Systemic Lupus Erythematosus and Sjogren's Syndrome, sponsored by NYU Langone Health.
NCT00074373 is a study of Systemic Lupus Erythematosus and Sjogren's Syndrome that has completed, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 379-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00074373, a study of Systemic Lupus Erythematosus and Sjogren's Syndrome, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Women with lupus and other related disorders produce certain antibodies in the blood. Some women have these antibodies even if they have not yet developed symptoms of lupus or Sjogren's syndrome. When these women become pregnant, they may pass the antibodies to their infants. The infants may then develop a disease called neonatal lupus. The symptoms of neonatal lupus include an abnormally slow heart beat (heart block) and a skin rash. This registry collects information on women and infants affected by neonatal lupus as well as other family members who may be healthy.
Primary Outcome
means of curing and/or preventing neonatal lupus
Conditions Studied
Interventions
- OTHER No intervention; observational
Study Locations (1)
New York
- Jill P. Buyon, MD - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-05-27 |
| Est. Completion | 2016-06 |
What the finished NCT00074373 record still lists
NCT00074373 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 379-participant average among 99 other Systemic Lupus Erythematosus trials with a reported enrollment target (74% lower).
The record links to 4 conditions, with Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 1 intervention - of which No intervention; observational is the first listed.
NCT00074373 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00074373 about?
NCT00074373 is a clinical study titled "The Research Registry for Neonatal Lupus". Women with lupus and other related disorders produce certain antibodies in the blood. Some women have these antibodies even if they have not yet developed symptoms of lupus or Sjogren's syndrome. When these women become pregnant, they may pass the antibodies to their infants. The infants may then de...
What is the current status of trial NCT00074373?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2010-05-27. Estimated completion is 2016-06.
What conditions does trial NCT00074373 study?
This clinical trial studies the following conditions: Systemic Lupus Erythematosus, Sjogren's Syndrome, Neonatal Lupus, Congenital Heart Block.
What interventions are being tested in trial NCT00074373?
The interventions under investigation include: No intervention; observational (OTHER).
Who is sponsoring clinical trial NCT00074373?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00074373 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00074373's enrollment target sits among peer trials
100 55th of 99 higher than 44 of 99 other Systemic Lupus Erythematosus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Systemic Lupus Erythematosus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
RECRUITING · Phase 3
-
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
RECRUITING · Phase 1
-
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
RECRUITING · Phase 1
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
RECRUITING
-
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI